Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
111.64B | 110.39B | 105.20B | 106.17B | 95.71B | 65.83B | Gross Profit |
62.28B | 62.14B | 57.27B | 54.17B | 45.19B | 28.36B | EBIT |
38.56B | 38.07B | 33.42B | 32.29B | 26.64B | 11.34B | EBITDA |
44.76B | 46.71B | 36.80B | 39.10B | 32.48B | 17.59B | Net Income Common Stockholders |
27.89B | 27.74B | 21.38B | 20.68B | 16.67B | 5.33B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
40.12B | 34.98B | 37.41B | 29.29B | 29.36B | 20.53B | Total Assets |
161.04B | 151.82B | 138.02B | 126.38B | 127.41B | 95.20B | Total Debt |
21.12B | 21.08B | 21.73B | 19.71B | 19.43B | 15.48B | Net Debt |
-19.00B | -13.90B | -15.68B | -9.57B | -9.93B | -5.05B | Total Liabilities |
64.25B | 55.90B | 53.06B | 52.61B | 63.27B | 41.90B | Stockholders Equity |
96.79B | 95.92B | 84.95B | 72.89B | 63.73B | 53.30B |
Cash Flow | Free Cash Flow | ||||
0.00 | 26.36B | 16.52B | 9.55B | 20.55B | 10.45B | Operating Cash Flow |
0.00 | 40.43B | 27.46B | 21.34B | 25.80B | 13.19B | Investing Cash Flow |
0.00 | -22.32B | -10.87B | -9.45B | -12.43B | -2.47B | Financing Cash Flow |
0.00 | -21.29B | -10.34B | -12.54B | -5.78B | -4.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥321.10B | 17.35 | 13.42% | 5.75% | 14.76% | 36.76% | |
79 Outperform | ¥365.30B | 12.81 | 3.03% | 4.94% | 31.90% | ||
71 Outperform | $301.69B | 7.91 | 9.28% | 0.03% | 2.73% | ― | |
62 Neutral | $278.15B | 24.02 | -0.56% | 3.77% | 3.02% | 48.28% | |
62 Neutral | $11.97B | 10.08 | -7.46% | 2.96% | 7.37% | -8.22% | |
60 Neutral | ¥344.07B | 824.45 | 0.43% | 1.23% | -0.23% | -91.55% | |
52 Neutral | ¥309.57B | 132.04 | 3.65% | 5.82% | -71.99% |
Dexerials Corporation announced an additional cash contribution of ¥1,000 million to its Board Benefit Trust-Restricted Stock system to acquire up to 700,000 common shares. This move aims to sustain the company’s stock compensation plan for directors, potentially strengthening its governance and aligning management interests with shareholders.
Dexerials Corporation reported a strong financial performance for the fiscal year ending March 31, 2025, with net sales increasing by 4.9% to 110,390 million yen and a significant rise in operating profit by 24.6%. The company also conducted a 3-for-1 stock split, impacting earnings per share calculations. Despite the positive results, the forecast for the next fiscal year indicates a decline in net sales and profits, suggesting potential challenges ahead.
Dexerials Corporation has been recognized for the fifth consecutive year as a Health and Productivity Management Organization 2025, highlighting its commitment to employee health and strategic management practices. The company has implemented initiatives like a health point system and team awards to promote physical and mental well-being, aiming to enhance employee capabilities and maintain a healthy work environment.
Dexerials Corporation’s 2024 Integrated Report has been recognized as an ‘Excellent Integrated Report’ by asset managers of the Government Pension Investment Fund. This recognition highlights Dexerials’ strategic focus on sustainability and its medium- to long-term growth plans, which align with its purpose of empowering evolution by connecting people and technology. The report emphasizes a future-oriented approach, detailing the company’s growth strategy, sustainability goals, and key ESG issues, thereby enhancing stakeholder understanding and corporate value.